AI-generated content may sometimes contain inaccurate, incomplete, or biased information, so make sure you do additional research. You should not rely on this feature for medical, financial, or legal advice. What is Livagen Peptide and How Does it Work in the Human Body? We weren’t able to create a summary for you. Refresh your page to try again. Mar 18, 2026 · Livagen (Lys-Glu-Asp-Ala, KEDA) is a synthetic tetrapeptide developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as a liver-derived peptide bioregulator. Mar 18, 2026 · Livagen (Lys-Glu-Asp-Ala, KEDA) is a synthetic tetrapeptide developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as a liver-derived peptide bioregulator. Jan 31, 2026 · Within a peptide-focused protocol, Livagen serves as an upstream epigenetic intervention that may enhance effectiveness of other compounds. By restoring chromatin accessibility, it potentially improves cellular responsiveness to anabolic signals from growth hormone secretagogues. Mar 18, 2026 · Livagen (Lys-Glu-Asp-Ala, KEDA) is a synthetic tetrapeptide developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as a liver-derived peptide bioregulator. Livagen is a short bioregulatory tetrapeptide that decondenses chromatin to reactivate silenced genes, with research applications in immune system rejuvenation, cardiac health, pain modulation, GI protection, and aging. Summary: Livagen is a bioregulatory thymic-derived peptide that supports cellular function through intracellular mechanisms involving gene expression regulation, chromatin remodeling, and cellular stress response support.